Benjamin F. Edwards & Company, Inc. Care Dx, Inc. Call Options Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDNA
# of Institutions
219Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$113 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$78.4 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$74.4 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$50.7 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.33B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...